RCKT ROCKET PHARMACEUTICALS INC

Ownership history in WOLVERINE TRADING, LLC  ·  17 quarters on record

This page tracks every 13F SEC filing in which WOLVERINE TRADING, LLC reported a position in ROCKET PHARMACEUTICALS INC (RCKT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 13,700 -34,800 -71.8% 0.00% $45K $3.26
2025 Q3 ADDED 48,500 +33,069 +214.3% 0.00% $159K $3.26
2025 Q2 REDUCED 15,431 -20,669 -57.3% 0.00% $39K $2.45
2025 Q2 ADDED 36,100 +23,400 +184.3% 0.00% $91K $2.45
2025 Q1 REDUCED 12,700 -23,300 -64.7% 0.00% $96K $6.67
2025 Q1 ADDED 36,000 +18,412 +104.7% 0.00% $273K $6.67
2024 Q4 REDUCED 17,588 -912 -4.9% 0.00% $212K $12.57
2024 Q4 ADDED 18,500 +4,900 +36.0% 0.00% $223K $12.57
2024 Q2 ADDED 13,600 +3,200 +30.8% 0.00% $293K $21.53
2024 Q1 ADDED 10,400 +2,500 +31.6% 0.00% $280K $26.94
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RCKT price (monthly, adj. close)
← Back to WOLVERINE TRADING, LLC Holdings